Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
Merck
Chubb
US Army
Julphar

Generated: April 25, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: Apotex Inc

« Back to Dashboard

Apotex Inc Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Apotex Inc pregabalin 203022 50MG CAPSULE;ORAL
Apotex Inc sitagliptin phosphate 202425 100MG TABLET; ORAL
Apotex Inc olopatadine hydrochloride 090918 0.2% BASE SOLUTION; OPHTHALMIC
Apotex Inc atomoxetine hydrochloride 078983 60MG CAPSULE; ORAL
Apotex Inc hydrochlorothiazide; irbesartan 201505 12.5MG;150MG TABLET;ORAL
Apotex Inc eletriptan hydrobromide 201536 40MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Colorcon
Deloitte
Argus Health
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.